Stay updated on Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Sign up to get notified when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.

Latest updates to the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s revision label was updated from v3.5.2 to v3.5.3, indicating a minor system/version change for the record history interface.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision entry added: v3.5.2. Previous entry v3.5.0 was removed from the history.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision v3.5.0 has been added and revision v3.4.3 has been removed.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision history shows an addition of revision v3.4.3 and a deletion of revision v3.4.2 from the record history.SummaryDifference0.1%

- Check69 days agoChange DetectedStudy Status and Recruitment Status were updated to Active, not recruiting, and the Contacts/Locations section was added/updated in the latest version (v43) with the dates 2026-03-03 and 2026-03-04.SummaryDifference0.4%

- Check91 days agoChange DetectedRevision: v3.4.2 was added, the previous v3.4.1 revision label and a government-funding notice banner were removed; these are minor site maintenance/versioning updates that do not alter study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.